ES2141534T3 - Preparado terapeutico para la aplicacion percutanea de principios activos a traves de la piel. - Google Patents
Preparado terapeutico para la aplicacion percutanea de principios activos a traves de la piel.Info
- Publication number
- ES2141534T3 ES2141534T3 ES96931820T ES96931820T ES2141534T3 ES 2141534 T3 ES2141534 T3 ES 2141534T3 ES 96931820 T ES96931820 T ES 96931820T ES 96931820 T ES96931820 T ES 96931820T ES 2141534 T3 ES2141534 T3 ES 2141534T3
- Authority
- ES
- Spain
- Prior art keywords
- skin
- active principles
- therapeutic preparation
- percutaneous application
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PREPARADO TRANSDERMICO PARA LA APLICACION TRANSDERMICA DE PRINCIPIOS ACTIVOS A TRAVES DE LA PIEL QUE CONTIENE UNOS ADITIVOS QUE AUMENTAN EL INDICE DE ABSORCION PERCUTANEA DE PRINCIPIOS ACTIVOS QUE NORMALMENTE SE ABSORBEN MAL POR LA PIEL. EL PREPARADO SE CARACTERIZA PORQUE LOS ADITIVOS SON SUSTANCIAS INHIBIDORADAS DE LA HMG-COA-REDUCTASA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19541260A DE19541260A1 (de) | 1995-11-06 | 1995-11-06 | Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2141534T3 true ES2141534T3 (es) | 2000-03-16 |
Family
ID=7776710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96931820T Expired - Lifetime ES2141534T3 (es) | 1995-11-06 | 1996-09-21 | Preparado terapeutico para la aplicacion percutanea de principios activos a traves de la piel. |
Country Status (21)
Country | Link |
---|---|
US (1) | US6379696B1 (es) |
EP (1) | EP0859595B1 (es) |
JP (1) | JP2001507331A (es) |
KR (1) | KR100445940B1 (es) |
CN (1) | CN1201385A (es) |
AT (1) | ATE186209T1 (es) |
AU (1) | AU716896B2 (es) |
CZ (1) | CZ289143B6 (es) |
DE (2) | DE19541260A1 (es) |
ES (1) | ES2141534T3 (es) |
GR (1) | GR3032523T3 (es) |
IL (1) | IL124279A (es) |
MX (1) | MX9803563A (es) |
MY (1) | MY132407A (es) |
NO (1) | NO982006L (es) |
NZ (1) | NZ318783A (es) |
PL (1) | PL326497A1 (es) |
PT (1) | PT859595E (es) |
SK (1) | SK281405B6 (es) |
WO (1) | WO1997017061A1 (es) |
ZA (1) | ZA969271B (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19830732B4 (de) * | 1998-07-09 | 2008-11-13 | Lts Lohmann Therapie-Systeme Ag | Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung |
CN100421653C (zh) * | 2000-09-08 | 2008-10-01 | 阿尔扎公司 | 通过抑制通道关闭来抑制药物透皮通量减少的方法 |
US20020187169A1 (en) * | 2001-05-11 | 2002-12-12 | Shoujun Chen | Kavalactone compositions |
EP1651197A1 (en) * | 2003-07-28 | 2006-05-03 | ALZA Corporation | Transdermal warfarin-containing delivery system |
KR20060135826A (ko) * | 2004-03-31 | 2006-12-29 | 코와 가부시키가이샤 | 외용제 |
AU2007245410A1 (en) * | 2006-04-26 | 2007-11-08 | Rosemont Pharmaceuticals Ltd | Liquid oral compositions |
JP5230613B2 (ja) | 2006-05-23 | 2013-07-10 | テラコス・インコーポレイテッド | グルコース輸送体阻害剤およびその使用方法 |
US8748419B2 (en) | 2006-06-16 | 2014-06-10 | Theracos, Inc. | Treating obesity with muscarinic receptor M1 antagonists |
US7893053B2 (en) | 2006-06-16 | 2011-02-22 | Theracos, Inc. | Treating psychological conditions using muscarinic receptor M1 antagonists |
US7652767B2 (en) * | 2006-10-19 | 2010-01-26 | Sporian Microsystems, Inc. | Optical sensor with chemically reactive surface |
US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
WO2008115224A2 (en) * | 2007-03-20 | 2008-09-25 | Bayer Healthcare Llc | Method of analyzing an analyte |
AR065913A1 (es) | 2007-04-02 | 2009-07-08 | Theracos Inc | Derivados de glicosido bencilico, composicion y combinacion farmaceutica y uso |
JP4809931B2 (ja) | 2007-08-23 | 2011-11-09 | セラコス・インコーポレイテッド | ベンジルベンゼン誘導体およびその使用方法 |
BRPI0916769A2 (pt) | 2008-07-15 | 2017-09-26 | Theracos Inc | derivados de benzilbenzeno deuterados e métodos de uso |
US8283454B2 (en) | 2008-08-22 | 2012-10-09 | Theracos, Inc. | Processes for the preparation of SGLT2 inhibitors |
ES2554375T3 (es) | 2008-11-25 | 2015-12-18 | University Of Rochester | Inhibidores de las MLK y métodos de uso |
EP2445506B1 (en) | 2009-06-24 | 2014-12-31 | Entarco SA | The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer |
JP5927506B2 (ja) | 2010-04-13 | 2016-06-01 | レルマダ セラピューティクス、インク. | 1−メチル−2’,6’−ピペコロキシリダイドの皮膚医薬組成物および使用方法 |
JP6086326B2 (ja) | 2010-05-24 | 2017-03-01 | ユニヴァーシティー オブ ロチェスター | 二環式ヘテロアリールキナーゼ阻害剤および使用方法 |
WO2011153712A1 (en) | 2010-06-12 | 2011-12-15 | Theracos, Inc. | Crystalline form of benzylbenzene sglt2 inhibitor |
WO2012085683A1 (en) | 2010-12-22 | 2012-06-28 | Entarco Sa | The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents |
EP2675893B1 (en) | 2011-02-18 | 2019-01-09 | The Scripps Research Institute | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate |
WO2014085795A1 (en) | 2012-11-30 | 2014-06-05 | University Of Rochester | Mixed lineage kinase inhibitors for hiv/aids therapies |
US9420820B2 (en) | 2013-08-09 | 2016-08-23 | University Of Tsukuba | Method for isolating polyphenols from olive mill water |
EP3119394B1 (en) | 2014-03-19 | 2021-05-12 | Curza Global LLC | Compositions and methods comprising 2-(acylamino)imidazoles |
WO2018184019A1 (en) | 2017-03-31 | 2018-10-04 | Curza Global, Llc | Compositions and methods comprising substituted 2-aminoimidazoles |
JP2021534196A (ja) | 2018-08-23 | 2021-12-09 | シージェン インコーポレイテッド | 抗tigit抗体 |
AU2021376218A1 (en) | 2020-11-08 | 2023-06-15 | Seagen Inc. | Combination Therapy |
KR20230165911A (ko) | 2021-04-09 | 2023-12-05 | 씨젠 인크. | 항-tigit 항체를 사용한 암의 치료 방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3634016A1 (de) * | 1986-04-17 | 1987-10-29 | Lohmann Gmbh & Co Kg | Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung |
US5211947A (en) * | 1988-12-16 | 1993-05-18 | Schering Corporation | Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor |
US5316765A (en) * | 1989-09-07 | 1994-05-31 | Karl Folkers Foundation For Biomedical And Clinical Research | Use of coenzyme Q10 in combination with HMG-CoA reductase inhibitor therapies |
AU7547891A (en) * | 1990-03-30 | 1991-10-30 | Yasunori Morimoto | Percutaneously absorbable composition of narcotic and nonnarcotic analgesics |
IL109037A (en) * | 1993-03-19 | 1999-01-26 | Cellegy Pharma Inc | Preparations for causing phase separation of lipid layers and preparation of the above preparations |
DE4341444C2 (de) * | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung |
US5968983A (en) * | 1994-10-05 | 1999-10-19 | Nitrosystems, Inc | Method and formulation for treating vascular disease |
-
1995
- 1995-11-06 DE DE19541260A patent/DE19541260A1/de not_active Withdrawn
-
1996
- 1996-09-21 KR KR10-1998-0703316A patent/KR100445940B1/ko not_active IP Right Cessation
- 1996-09-21 PT PT96931820T patent/PT859595E/pt unknown
- 1996-09-21 JP JP51777797A patent/JP2001507331A/ja active Pending
- 1996-09-21 IL IL12427997A patent/IL124279A/xx not_active IP Right Cessation
- 1996-09-21 DE DE59603597T patent/DE59603597D1/de not_active Expired - Lifetime
- 1996-09-21 EP EP96931820A patent/EP0859595B1/de not_active Expired - Lifetime
- 1996-09-21 ES ES96931820T patent/ES2141534T3/es not_active Expired - Lifetime
- 1996-09-21 CN CN96198113A patent/CN1201385A/zh active Pending
- 1996-09-21 WO PCT/EP1996/004138 patent/WO1997017061A1/de active IP Right Grant
- 1996-09-21 CZ CZ19981366A patent/CZ289143B6/cs not_active IP Right Cessation
- 1996-09-21 US US09/068,326 patent/US6379696B1/en not_active Expired - Lifetime
- 1996-09-21 AU AU70859/96A patent/AU716896B2/en not_active Ceased
- 1996-09-21 NZ NZ318783A patent/NZ318783A/en unknown
- 1996-09-21 AT AT96931820T patent/ATE186209T1/de active
- 1996-09-21 PL PL96326497A patent/PL326497A1/xx unknown
- 1996-09-21 SK SK558-98A patent/SK281405B6/sk unknown
- 1996-11-04 MY MYPI96004590A patent/MY132407A/en unknown
- 1996-11-05 ZA ZA969271A patent/ZA969271B/xx unknown
-
1998
- 1998-05-04 NO NO982006A patent/NO982006L/no not_active Application Discontinuation
- 1998-05-06 MX MX9803563A patent/MX9803563A/es not_active IP Right Cessation
-
2000
- 2000-01-31 GR GR20000400219T patent/GR3032523T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL326497A1 (en) | 1998-09-28 |
MY132407A (en) | 2007-10-31 |
CZ136698A3 (cs) | 1998-07-15 |
WO1997017061A1 (de) | 1997-05-15 |
MX9803563A (es) | 1998-09-30 |
EP0859595B1 (de) | 1999-11-03 |
GR3032523T3 (en) | 2000-05-31 |
PT859595E (pt) | 2000-04-28 |
KR19990067320A (ko) | 1999-08-16 |
SK281405B6 (sk) | 2001-03-12 |
KR100445940B1 (ko) | 2005-09-30 |
ATE186209T1 (de) | 1999-11-15 |
EP0859595A1 (de) | 1998-08-26 |
IL124279A (en) | 2003-07-06 |
NZ318783A (en) | 1999-04-29 |
NO982006D0 (no) | 1998-05-04 |
AU716896B2 (en) | 2000-03-09 |
DE19541260A1 (de) | 1997-05-07 |
ZA969271B (en) | 1997-06-03 |
US6379696B1 (en) | 2002-04-30 |
JP2001507331A (ja) | 2001-06-05 |
NO982006L (no) | 1998-05-04 |
CZ289143B6 (cs) | 2001-11-14 |
AU7085996A (en) | 1997-05-29 |
CN1201385A (zh) | 1998-12-09 |
DE59603597D1 (de) | 1999-12-09 |
SK55898A3 (en) | 1998-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2141534T3 (es) | Preparado terapeutico para la aplicacion percutanea de principios activos a traves de la piel. | |
ES2183186T3 (es) | Composiciones cosmeticas en polvo que contienen elastomeros de silicona. | |
NL350039I1 (nl) | Insecticide actieve nitroverbindingen | |
NO904099L (no) | Pulserende doseringssystem for tilfoersel av minocyclin en gang pr. dag. | |
ES2124570T3 (es) | Compuestos dihalopropeno, agentes insecticidas/acaricidas que los contienen e intermediarios para su fabricacion. | |
MX161285A (es) | Mejoras a vendaje o parche para coadministrar una droga y un mejorador de absorcion percutanea a un area predeterminada de piel no rota,durante un tiempo predeterminado | |
ES2167592T3 (es) | Preparaciones medicamentosas que contienen un enantiomero de bromuro de ipratropio con duracion de la accion prolongada. | |
ES2145301T3 (es) | Compuestos a base de dihalopropeno, agentes insecticidas que los contienen y productos intermediarios que sirven para producirlo. | |
ES2100970T3 (es) | Preparacion para uso externo para aplicacion sobre la piel a base de lidocaina. | |
ES2183180T3 (es) | Nuevos derivados de guanidina, procedimientos para su preparacion y su uso como medicamento. | |
DK0654967T3 (da) | Anvendelse af kokosfedtsyreprækursor som insektrepellent | |
ES2184131T3 (es) | Derivados de benzamidina y su utilizacion como medicamentos con efecto antagonista de ltb4. | |
ES2032818T3 (es) | N-acil-n'-alquilocarbonilhidrazinas n'-sustituidas utiles como insecticidas. | |
TR200003156T2 (tr) | Bir aktif içerik olarak izomalt içeren terapötik soğuk algınlığına karşı ajan. | |
ES491307A0 (es) | Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal | |
ES2021167B3 (es) | Derivados de pirazol y composiciones insecticidas, miticidas y fungicidas que los contienen, como ingrediente activo | |
ES2080037T1 (es) | Medicamento de uso topico con actividad cicatrizante. | |
ES2094834T3 (es) | Dispositivo para el lavado, para finalidades terapeuticas o de higiene, de conductos internos humanos o animales. | |
ES2181670T3 (es) | Peptidos que conservan una actividad similar a la de la tromboespondina y su utilizacion terapeutica. | |
AR002247A1 (es) | Eleuterobina y analogos de la misma y composiciones que las comprenden. | |
PL202199A1 (pl) | Srodek pasozytobojczy do zwalczania szkodliwych mikroorganizmow | |
ATE158947T1 (de) | Hautregenerierende kosmetische zusammensetzung | |
ES2138602T3 (es) | Agente terapeutico para la amenaza de aborto. | |
DK0469440T3 (da) | Faste orale applikationsformer, der som aktivt stof indeholder ifosamid | |
AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 859595 Country of ref document: ES |